REKR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. REKR is in a strong downtrend (bearish moving-average stack and worsening MACD), and pattern-based stats also lean to further downside over 1 day/1 week/1 month. Despite being extremely oversold (RSI_6 ~10.7) and showing a pre-market pop, there’s no Intellectia buy signal to prioritize, and the broader setup still favors avoiding/ selling into any bounce rather than buying immediately.
Trend & momentum: Clearly bearish. SMA_200 > SMA_20 > SMA_5 confirms a sustained downtrend. MACD histogram (-0.0323) is below zero and negatively expanding, signaling downside momentum is still strengthening. Overbought/oversold: RSI_6 at 10.746 is extremely oversold, which can produce short-lived bounce attempts, but oversold alone is not a reliable reversal signal when trend/momentum remain bearish. Levels: Current price 1.115 is below the Pivot (1.331). Nearest supports are S1 1.136 (already essentially lost) and S2 1.016. Upside resistance levels are R1 1.526 and R2 1.646—well above current price, implying any bounce likely faces heavy overhead supply. Near-term bias from similar-pattern study: 60% probability of -0.55% next day, -1.07% next week, and -6% next month—bearish skew.
Intellectia Proprietary Trading Signals
Technical: Extremely oversold RSI increases the odds of a reflex bounce.
Options positioning: Very low put/call open interest ratio (0.
suggests market participants are positioned more bullish than bearish.
Fundamentals: 2025/Q3 revenue grew +34.59% YoY and gross margin improved to 52.52% (material YoY expansion).
Technical: Strong downtrend (SMA200>SMA20>SMA
plus MACD histogram worsening—trend still points lower.
Price structure: Trading well below pivot (1.
with nearby support risk toward ~1.
Quant/pattern outlook: Similar-candlestick study indicates bearish drift over next day/week/month.
Fundamentals: Profitability deteriorated—2025/Q3 net income fell to -$4.149M (more negative YoY), EPS -0.03 (worse YoY).
News flow: No recent news catalysts to force a re-rating or trend reversal.
Influential/Political flows: No recent congress trading data available; hedge funds and insiders reported as neutral (no supportive buying trend).
Latest reported quarter: 2025/Q3. Revenue rose to $14.194M (+34.59% YoY), indicating strong top-line growth. However, earnings quality weakened: net income was -$4.149M (more negative YoY) and EPS was -0.03 (worse YoY). A bright spot is gross margin at 52.52% with a large YoY increase, suggesting improved unit economics, but the company is still not translating that into bottom-line improvement yet.
No analyst rating or price target change data was provided, so a recent Wall Street upgrades/downgrades trend cannot be confirmed here. Based on the available data only, the ‘pro’ view would emphasize accelerating revenue and sharply improved gross margin, while the ‘con’ view is ongoing losses/weakening EPS and a technically broken chart.
